These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
25. Direct thrombin inhibitors for management of heparin-induced thrombocytopenia in patients receiving renal replacement therapy: comparison of clinical outcomes. Abel EE; Kane-Gill SL; Seybert AL; Kellum JA Am J Health Syst Pharm; 2012 Sep; 69(18):1559-67. PubMed ID: 22935938 [TBL] [Abstract][Full Text] [Related]
26. Argatroban: a review of its use in the management of heparin-induced thrombocytopenia. Dhillon S Am J Cardiovasc Drugs; 2009; 9(4):261-82. PubMed ID: 19655821 [TBL] [Abstract][Full Text] [Related]
32. Direct thrombin inhibition during percutaneous coronary intervention in patients with heparin-induced thrombocytopenia. Lewis BE; Hursting MJ Expert Rev Cardiovasc Ther; 2007 Jan; 5(1):57-68. PubMed ID: 17187457 [TBL] [Abstract][Full Text] [Related]
33. Argatroban anticoagulation in patients with heparin-induced thrombocytopenia. Lewis BE; Wallis DE; Leya F; Hursting MJ; Kelton JG; Arch Intern Med; 2003 Aug 11-25; 163(15):1849-56. PubMed ID: 12912723 [TBL] [Abstract][Full Text] [Related]
34. Differences in the clinically effective molar concentrations of four direct thrombin inhibitors explain their variable prothrombin time prolongation. Warkentin TE; Greinacher A; Craven S; Dewar L; Sheppard JA; Ofosu FA Thromb Haemost; 2005 Nov; 94(5):958-64. PubMed ID: 16363236 [TBL] [Abstract][Full Text] [Related]
35. Heparin-Induced Thrombocytopenia in Infants after Heart Surgery. Abdillah JN; Hu Q; Chen X; Chen X; Zhou W; Luo W; Huang L Thorac Cardiovasc Surg; 2019 Jan; 67(1):21-27. PubMed ID: 29605959 [TBL] [Abstract][Full Text] [Related]
36. Argatroban therapy for heparin-induced thrombocytopenia in acutely ill patients. Gray A; Wallis DE; Hursting MJ; Katz E; Lewis BE Clin Appl Thromb Hemost; 2007 Oct; 13(4):353-61. PubMed ID: 17911186 [TBL] [Abstract][Full Text] [Related]
37. Antithrombotic drugs for the treatment of heparin-induced thrombocytopenia. Jeske WP; Walenga JM Curr Opin Investig Drugs; 2002 Aug; 3(8):1171-80. PubMed ID: 12211410 [TBL] [Abstract][Full Text] [Related]
38. Evaluation of intravenous direct thrombin inhibitor monitoring tests: Correlation with plasma concentrations and clinical outcomes in hospitalized patients. Beyer JT; Lind SE; Fisher S; Trujillo TC; Wempe MF; Kiser TH J Thromb Thrombolysis; 2020 Feb; 49(2):259-267. PubMed ID: 31559512 [TBL] [Abstract][Full Text] [Related]
39. Argatroban in HIT type II and acute coronary syndrome. Lewis BE; Walenga JM Pathophysiol Haemost Thromb; 2002; 32 Suppl 3():46-55. PubMed ID: 12811012 [TBL] [Abstract][Full Text] [Related]
40. Heparin-induced thrombocytopenia in intensive care patients. Selleng K; Warkentin TE; Greinacher A Crit Care Med; 2007 Apr; 35(4):1165-76. PubMed ID: 17334253 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]